EA200000127A1 - METHOD OF OBTAINING AMINO DERIVATIVES OF ALKYLOXYFURANON OBTAINED BY THIS METHOD OF CONNECTION AND USE OF THESE COMPOUNDS - Google Patents
METHOD OF OBTAINING AMINO DERIVATIVES OF ALKYLOXYFURANON OBTAINED BY THIS METHOD OF CONNECTION AND USE OF THESE COMPOUNDSInfo
- Publication number
- EA200000127A1 EA200000127A1 EA200000127A EA200000127A EA200000127A1 EA 200000127 A1 EA200000127 A1 EA 200000127A1 EA 200000127 A EA200000127 A EA 200000127A EA 200000127 A EA200000127 A EA 200000127A EA 200000127 A1 EA200000127 A1 EA 200000127A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- alkyloxyfuranon
- connection
- formula
- amino derivatives
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 150000001412 amines Chemical class 0.000 title 1
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000003777 Interleukin-1 beta Human genes 0.000 abstract 1
- 108090000193 Interleukin-1 beta Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B57/00—Separation of optically-active compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Предметом изобретения является новый способ получения соединений формулы (IV) или (I), исходя из рацемического алкилоксифуранона формулы (II), при этом Rи Rопределены в описании, новые соединения формулы (IV), а также промежуточные соединения этого способа и применение соединений формулы (IV) или (I) в способе синтеза соединений - ингибиторов фермента преобразования интерлейкина-1бета.Международная заявка была опубликована вместе с отчетом о международном поиске.The subject of the invention is a new method for producing compounds of formula (IV) or (I), based on racemic alkyloxyfuranone of formula (II), with R and R being defined in the description, new compounds of formula (IV), as well as intermediates of this method and the use of compounds of formula ( Iv) or (i) in the synthesis of compounds that inhibit the enzyme of the conversion of interleukin-1beta. The international application was published together with an international search report.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9708932A FR2766188B1 (en) | 1997-07-15 | 1997-07-15 | NOVEL PROCESS FOR THE PREPARATION OF AMINO DERIVATIVES OF ALKYLOXY FURANONE, COMPOUNDS ARISING FROM THIS PROCESS AND USE OF SUCH COMPOUNDS |
| PCT/FR1998/001480 WO1999003852A1 (en) | 1997-07-15 | 1998-07-09 | Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200000127A1 true EA200000127A1 (en) | 2000-08-28 |
| EA002883B1 EA002883B1 (en) | 2002-10-31 |
Family
ID=9509210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200000127A EA002883B1 (en) | 1997-07-15 | 1998-07-09 | Method for preparing alkyloxy firanone derivatives, compounds obtained by said method and use of said compounds |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6235899B1 (en) |
| EP (1) | EP0998470B1 (en) |
| JP (1) | JP4450987B2 (en) |
| KR (1) | KR100519691B1 (en) |
| CN (1) | CN100363355C (en) |
| AP (1) | AP1071A (en) |
| AR (1) | AR015924A1 (en) |
| AT (1) | ATE239713T1 (en) |
| AU (1) | AU744272B2 (en) |
| BG (1) | BG64050B1 (en) |
| BR (1) | BR9810896A (en) |
| CA (1) | CA2296742C (en) |
| CZ (1) | CZ295312B6 (en) |
| DE (1) | DE69814395T2 (en) |
| DK (1) | DK0998470T3 (en) |
| EA (1) | EA002883B1 (en) |
| EE (1) | EE03873B1 (en) |
| ES (1) | ES2197489T3 (en) |
| FR (1) | FR2766188B1 (en) |
| HR (1) | HRP20000027B1 (en) |
| HU (1) | HU230148B1 (en) |
| ID (1) | ID23784A (en) |
| IL (1) | IL134031A (en) |
| ME (1) | ME01708B (en) |
| NO (1) | NO324508B1 (en) |
| NZ (1) | NZ502338A (en) |
| PL (1) | PL200820B1 (en) |
| PT (1) | PT998470E (en) |
| RS (1) | RS49832B (en) |
| SK (1) | SK284168B6 (en) |
| TR (1) | TR200000117T2 (en) |
| UA (1) | UA66364C2 (en) |
| WO (1) | WO1999003852A1 (en) |
| ZA (1) | ZA986203B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053056B2 (en) * | 1998-07-02 | 2006-05-30 | Idun Pharmaceuticals, Inc. | C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| DE60142470D1 (en) | 2000-04-24 | 2010-08-12 | Vertex Pharma | METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF SUBSTITUTED ASPARAGINIC ACETALES |
| PE20011350A1 (en) | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE) |
| JP2003327568A (en) * | 2000-09-20 | 2003-11-19 | Kanegafuchi Chem Ind Co Ltd | METHOD FOR PRODUCING OPTICALLY ACTIVE beta-AMINO ACID DERIVATIVE |
| JPWO2002055478A1 (en) * | 2001-01-16 | 2004-05-13 | 鐘淵化学工業株式会社 | Process for producing optically active aminolactone derivatives and intermediates thereof |
| EP1718639A2 (en) | 2004-02-27 | 2006-11-08 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
| CA2768700C (en) * | 2004-03-12 | 2014-04-29 | Vertex Pharmaceuticals Incorporated | Processes and intermediates for the preparation of aspartic acetal caspase inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
-
1997
- 1997-07-15 FR FR9708932A patent/FR2766188B1/en not_active Expired - Lifetime
-
1998
- 1998-07-09 RS YUP-15/00A patent/RS49832B/en unknown
- 1998-07-09 TR TR2000/00117T patent/TR200000117T2/en unknown
- 1998-07-09 EE EEP200000024A patent/EE03873B1/en unknown
- 1998-07-09 ME MEP-2000-15A patent/ME01708B/en unknown
- 1998-07-09 DE DE69814395T patent/DE69814395T2/en not_active Expired - Lifetime
- 1998-07-09 EP EP98937591A patent/EP0998470B1/en not_active Expired - Lifetime
- 1998-07-09 AT AT98937591T patent/ATE239713T1/en active
- 1998-07-09 IL IL13403198A patent/IL134031A/en not_active IP Right Cessation
- 1998-07-09 AU AU86333/98A patent/AU744272B2/en not_active Expired
- 1998-07-09 BR BR9810896-4A patent/BR9810896A/en not_active Application Discontinuation
- 1998-07-09 ES ES98937591T patent/ES2197489T3/en not_active Expired - Lifetime
- 1998-07-09 CN CNB98808967XA patent/CN100363355C/en not_active Expired - Lifetime
- 1998-07-09 DK DK98937591T patent/DK0998470T3/en active
- 1998-07-09 US US09/463,014 patent/US6235899B1/en not_active Expired - Lifetime
- 1998-07-09 SK SK30-2000A patent/SK284168B6/en not_active IP Right Cessation
- 1998-07-09 CZ CZ200065A patent/CZ295312B6/en not_active IP Right Cessation
- 1998-07-09 EA EA200000127A patent/EA002883B1/en not_active IP Right Cessation
- 1998-07-09 KR KR10-2000-7000398A patent/KR100519691B1/en not_active Expired - Lifetime
- 1998-07-09 HR HR20000027A patent/HRP20000027B1/en not_active IP Right Cessation
- 1998-07-09 JP JP2000503076A patent/JP4450987B2/en not_active Expired - Lifetime
- 1998-07-09 HU HU0003857A patent/HU230148B1/en unknown
- 1998-07-09 WO PCT/FR1998/001480 patent/WO1999003852A1/en not_active Ceased
- 1998-07-09 PT PT98937591T patent/PT998470E/en unknown
- 1998-07-09 NZ NZ502338A patent/NZ502338A/en not_active IP Right Cessation
- 1998-07-09 PL PL338035A patent/PL200820B1/en unknown
- 1998-07-09 AP APAP/P/2000/001732A patent/AP1071A/en active
- 1998-07-09 ID IDW20000067A patent/ID23784A/en unknown
- 1998-07-09 CA CA002296742A patent/CA2296742C/en not_active Expired - Lifetime
- 1998-07-13 ZA ZA9806203A patent/ZA986203B/en unknown
- 1998-07-15 AR ARP980103455A patent/AR015924A1/en not_active Application Discontinuation
- 1998-09-07 UA UA2000020800A patent/UA66364C2/en unknown
-
2000
- 2000-01-12 BG BG104073A patent/BG64050B1/en unknown
- 2000-01-14 NO NO20000182A patent/NO324508B1/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200101081A1 (en) | METHOD OF OBTAINING CYTALOPRAMA | |
| EA200101071A1 (en) | METHOD OF OBTAINING CYTALOPRAMA | |
| EA199800579A1 (en) | NEW DERIVATIVES 5-AMINO-3-CYANO-4-ETYLSULPHINYL-1-PHENYLPYRAZOLE AND THEIR USE AS PESTICIDES | |
| EA200001219A1 (en) | METHOD OF OBTAINING PLANTS RESISTANT TO MULTIPLE HERBICIDES, PLANT, OBTAINED BY THIS METHOD, AND ALSO USING THE METHOD OF TREATING PLANTS WITH HERBICIDES FOR TREATING SUCH PLANTS | |
| EA200401540A1 (en) | SPYROINDOLINPIPERIDINE DERIVATIVES | |
| EA199900643A1 (en) | SULFAMIDE METHOD PROTEASIS INHIBITORS | |
| EA200500037A1 (en) | Phenylbenzamide | |
| EA199800302A1 (en) | METHOD OF OBTAINING DIFTOROMETHANE | |
| EA199800106A1 (en) | COMPOUNDS AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
| EA199900279A1 (en) | DERIVATIVES OF BENZAMIDE AND THEIR APPLICATION AS MEDICINES WITH LTV4 ANTAGONISTIC ACTIVITY | |
| EA200000094A1 (en) | METHOD OF OBTAINING A SUBSTITUTED PERHYDROIZOINDOL | |
| EA199800792A1 (en) | METHODS OF OBTAINING INTERMEDIATE CONNECTIONS FOR PESTICIDES | |
| DE69735871D1 (en) | Synthesis of 9-deoxo-9a-aza 11,12-deoxy-9a-methyl-9a-homoerythromycin A 11,12-hydrogenorthoborate dihydrate | |
| EA199800844A1 (en) | METHOD OF OBTAINING R-ALPHA-PROPYL-PIPERONYLAMINE AND ITS ANALOGUES, INTERMEDIATE PRODUCTS USED IN THIS METHOD | |
| EA200400682A1 (en) | METHOD FOR OBTAINING CRYSTALLINE IMPENEM | |
| EA200300525A1 (en) | Glycosidation of indolcarbazole using interphase catalysis | |
| EA200400809A1 (en) | METHOD OF OBTAINING ESCITALOPRAMA | |
| EA200000127A1 (en) | METHOD OF OBTAINING AMINO DERIVATIVES OF ALKYLOXYFURANON OBTAINED BY THIS METHOD OF CONNECTION AND USE OF THESE COMPOUNDS | |
| EA200200381A1 (en) | TETRAHYDROTHIOPIRANTHTHALASINOIN DERIVATIVES AS INHIBITORS PDE4 | |
| EA200200101A1 (en) | RECEPTION OF SUBSTITUTED PIPERIDIN-4-ONES | |
| EA199900235A1 (en) | AMORPHOUS BENZOTHYPHENES, METHODS OF OBTAINING AND METHODS OF APPLICATION | |
| EA199900027A1 (en) | METHOD OF OBTAINING SOME AZACYCLOGEXPEPTIDES | |
| EA200100297A1 (en) | ELECTRIPTANE HYDROBROMIDE MONOHYDRATE | |
| EA200000322A1 (en) | METHOD FOR SYNTHESIS OF QUINOLINE DERIVATIVES | |
| EA199900281A1 (en) | STEREOSPECIFIC SYNTHESIS OF CHARAL 1-ARYL AND 1-HETEROARYL-2-SUBSTITUTED ETHYL-2-AMINS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MK4A | Patent expired |
Designated state(s): RU |